Answers are grounded in this paper and cite their sources.
This paper reports the synthesis, characterization, and cellular uptake of the conjugate of porphyrin and iron oxide nanoparticles, which may lead to a bimodal anticancer agent that can be used in the combinational treatment of photodynamic therapy (PDT) and hyperthermia therapy (HT).
No takes yet. Share an insight, caveat, or question.
Gu et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: